Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics
Gliomas harbouring mutations in IDH1 (isocitrate dehydrogenase 1) are characterized by greater sensitivity to chemotherapeutics. These mutants also exhibit diminished levels of transcriptional coactivator YAP1 (yes-associated protein 1). Enhanced DNA damage in IDH1 mutant cells, as evidenced by γH2A...
Saved in:
Published in | Cellular signalling Vol. 109; p. 110738 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Gliomas harbouring mutations in IDH1 (isocitrate dehydrogenase 1) are characterized by greater sensitivity to chemotherapeutics. These mutants also exhibit diminished levels of transcriptional coactivator YAP1 (yes-associated protein 1). Enhanced DNA damage in IDH1 mutant cells, as evidenced by γH2AX formation (phosphorylation of histone variant H2A.X) and ATM (serine/threonine kinase; ataxia telangiectasia mutated) phosphorylation, was accompanied by reduced FOLR1 (folate receptor 1) expression. Diminished FOLR1, concomitant with heightened γH2AX levels, was also observed in patient-derived IDH1 mutant glioma tissues. Chromatin immunoprecipitation, overexpression of mutant YAP1, and treatment with YAP1-TEAD (TEA domain transcription factors) complex inhibitor verteporfin demonstrated regulation of FOLR1 expression by YAP1 and its partner transcription factor TEAD2. TCGA (The Cancer Genome Atlas) data analysis demonstrated better patient survival with reduced FOLR1 expression. Depletion of FOLR1 rendered IDH1 wild-type gliomas more susceptible to temozolomide-mediated death. Despite heightened DNA damage, IDH1 mutants exhibited reduced levels of IL6 (interleukin 6) and IL8 (interleukin 8) – pro-inflammatory cytokines known to be associated with persistent DNA damage. While both FOLR1 and YAP1 influenced DNA damage, only YAP1 was involved in regulating IL6 and IL8. ESTIMATE and CIBERSORTx analyses revealed the association between YAP1 expression and immune cell infiltration in gliomas. By identifying the influence of YAP1-FOLR1 link in DNA damage, our findings suggest that simultaneous depletion of both could amplify the potency of DNA damaging agents, while concomitantly reducing the release of inflammatory mediators and potentially affecting immune modulation. This study also highlights the novel role of FOLR1 as a probable prognostic marker in gliomas, predicting responsiveness to temozolomide and other DNA damaging agents.
[Display omitted]
•IDH1 mutant gliomas with reduced YAP1 and FOLR1 levels exhibit elevated DNA damage.•YAP1 regulates FOLR1 expression.•FOLR1 depletion increases sensitivity of glioma cells to temozolomide.•YAP1 depletion increases DNA damage while reducing proinflammatory cytokine release.•FOLR1 is a potential prognostic marker for gliomas. |
---|---|
AbstractList | Gliomas harbouring mutations in IDH1 (isocitrate dehydrogenase 1) are characterized by greater sensitivity to chemotherapeutics. These mutants also exhibit diminished levels of transcriptional coactivator YAP1 (yes-associated protein 1). Enhanced DNA damage in IDH1 mutant cells, as evidenced by γH2AX formation (phosphorylation of histone variant H2A.X) and ATM (serine/threonine kinase; ataxia telangiectasia mutated) phosphorylation, was accompanied by reduced FOLR1 (folate receptor 1) expression. Diminished FOLR1, concomitant with heightened γH2AX levels, was also observed in patient-derived IDH1 mutant glioma tissues. Chromatin immunoprecipitation, overexpression of mutant YAP1, and treatment with YAP1-TEAD (TEA domain transcription factors) complex inhibitor verteporfin demonstrated regulation of FOLR1 expression by YAP1 and its partner transcription factor TEAD2. TCGA (The Cancer Genome Atlas) data analysis demonstrated better patient survival with reduced FOLR1 expression. Depletion of FOLR1 rendered IDH1 wild-type gliomas more susceptible to temozolomide-mediated death. Despite heightened DNA damage, IDH1 mutants exhibited reduced levels of IL6 (interleukin 6) and IL8 (interleukin 8) - pro-inflammatory cytokines known to be associated with persistent DNA damage. While both FOLR1 and YAP1 influenced DNA damage, only YAP1 was involved in regulating IL6 and IL8. ESTIMATE and CIBERSORTx analyses revealed the association between YAP1 expression and immune cell infiltration in gliomas. By identifying the influence of YAP1-FOLR1 link in DNA damage, our findings suggest that simultaneous depletion of both could amplify the potency of DNA damaging agents, while concomitantly reducing the release of inflammatory mediators and potentially affecting immune modulation. This study also highlights the novel role of FOLR1 as a probable prognostic marker in gliomas, predicting responsiveness to temozolomide and other DNA damaging agents. Gliomas harbouring mutations in IDH1 (isocitrate dehydrogenase 1) are characterized by greater sensitivity to chemotherapeutics. These mutants also exhibit diminished levels of transcriptional coactivator YAP1 (yes-associated protein 1). Enhanced DNA damage in IDH1 mutant cells, as evidenced by γH2AX formation (phosphorylation of histone variant H2A.X) and ATM (serine/threonine kinase; ataxia telangiectasia mutated) phosphorylation, was accompanied by reduced FOLR1 (folate receptor 1) expression. Diminished FOLR1, concomitant with heightened γH2AX levels, was also observed in patient-derived IDH1 mutant glioma tissues. Chromatin immunoprecipitation, overexpression of mutant YAP1, and treatment with YAP1-TEAD (TEA domain transcription factors) complex inhibitor verteporfin demonstrated regulation of FOLR1 expression by YAP1 and its partner transcription factor TEAD2. TCGA (The Cancer Genome Atlas) data analysis demonstrated better patient survival with reduced FOLR1 expression. Depletion of FOLR1 rendered IDH1 wild-type gliomas more susceptible to temozolomide-mediated death. Despite heightened DNA damage, IDH1 mutants exhibited reduced levels of IL6 (interleukin 6) and IL8 (interleukin 8) – pro-inflammatory cytokines known to be associated with persistent DNA damage. While both FOLR1 and YAP1 influenced DNA damage, only YAP1 was involved in regulating IL6 and IL8. ESTIMATE and CIBERSORTx analyses revealed the association between YAP1 expression and immune cell infiltration in gliomas. By identifying the influence of YAP1-FOLR1 link in DNA damage, our findings suggest that simultaneous depletion of both could amplify the potency of DNA damaging agents, while concomitantly reducing the release of inflammatory mediators and potentially affecting immune modulation. This study also highlights the novel role of FOLR1 as a probable prognostic marker in gliomas, predicting responsiveness to temozolomide and other DNA damaging agents. [Display omitted] •IDH1 mutant gliomas with reduced YAP1 and FOLR1 levels exhibit elevated DNA damage.•YAP1 regulates FOLR1 expression.•FOLR1 depletion increases sensitivity of glioma cells to temozolomide.•YAP1 depletion increases DNA damage while reducing proinflammatory cytokine release.•FOLR1 is a potential prognostic marker for gliomas. |
ArticleNumber | 110738 |
Author | Lathoria, Kirti Patrick, Shruti Suri, Vaishali Sen, Ellora |
Author_xml | – sequence: 1 givenname: Shruti surname: Patrick fullname: Patrick, Shruti organization: National Brain Research Centre, Manesar 122052, India – sequence: 2 givenname: Kirti surname: Lathoria fullname: Lathoria, Kirti organization: National Brain Research Centre, Manesar 122052, India – sequence: 3 givenname: Vaishali surname: Suri fullname: Suri, Vaishali organization: All India Institute of Medical Sciences, New Delhi 110029, India – sequence: 4 givenname: Ellora surname: Sen fullname: Sen, Ellora email: ellora@nbrc.ac.in organization: National Brain Research Centre, Manesar 122052, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37269960$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1P3DAQhq2KqizQn9DKRy5ZPDa2kxNCqHxIK6hQe-BkOfYEvNrEwXYq8e_Jardc0Rzm8rzzap4jcjDEAQn5AWwJDNTZeulws8nheckZF0sApkX9hSyg1qISDYgDsmB1U1dKqvqQHOW8ZgwkU_wbORSaq6ZRbEHuH9FPDj19uvwN1A6eXj-sHoGGgT5vQuxtpmNCH1yhLZaCiSbMYxwy0hKpe8E-lhdMdsSpBJdPyNfObjJ-3-9j8vf615-r22r1cHN3dbmqnFCyVIgg2Dz2XELXadDgZCeUA3uuoHFccK9awYH5utUtq9GxxntoJTKm7Bw8Jqe7u2OKrxPmYvqQt0LsgHHKhtecCy2l1jMqd6hLMeeEnRlT6G16M8DMVqVZm71Ks1Vpdirn3M99xdT26D9S_93NwMUOwPnRfwGTyS7gMMsMCV0xPoZPKt4BKyOHyQ |
CitedBy_id | crossref_primary_10_1016_j_jep_2024_118127 |
Cites_doi | 10.1002/ijc.30668 10.1038/nature09132 10.1016/j.canlet.2018.03.025 10.1016/j.gpb.2020.10.005 10.1038/ncomms3612 10.1101/gad.1664408 10.1038/labinvest.2017.19 10.1111/jnc.14152 10.1016/j.tem.2021.12.003 10.7554/eLife.52176 10.1158/2159-8290.CD-12-0095 10.1093/neuonc/not198 10.1093/nar/gkv468 10.4161/cbt.8.5.7740 10.1056/NEJMoa1402121 10.1080/1354750X.2020.1771420 10.1002/path.5133 10.1186/1471-2407-13-147 10.1111/j.1349-7006.2011.02134.x 10.1038/s41388-021-01878-3 10.1128/MCB.00001-18 10.1038/onc.2015.219 10.1021/acsomega.0c05500 10.1186/s12864-022-08586-6 10.1002/stem.188 10.1038/s41598-017-07632-8 10.1038/s41587-019-0114-2 10.1200/JCO.2009.21.9832 10.1097/NEN.0b013e31821ff8d8 10.1038/nature20602 10.1093/neuonc/now247 10.1101/gad.294991.116 10.1016/j.ccr.2010.12.014 10.3389/fcell.2021.729136 10.1016/j.cell.2011.02.013 10.1126/scitranslmed.aal2463 10.4061/2010/920161 10.1038/ncb1909 10.1016/j.cell.2008.03.039 10.3389/fonc.2018.00164 10.1186/s10020-019-0103-4 10.1016/j.cell.2005.06.007 10.1016/j.trecan.2020.05.004 10.1371/journal.pone.0096801 10.1084/jem.20181965 10.1038/s41388-021-01718-4 10.1038/nrc.2015.2 10.1016/j.cmet.2016.08.009 10.1158/1078-0432.CCR-06-1920 10.1056/NEJMoa0808710 10.1093/neuonc/nou005 10.18632/oncotarget.21913 10.15252/emmm.201707729 10.1016/j.ccell.2016.05.018 10.1158/1541-7786.MCR-21-0284 10.1371/journal.pone.0051862 10.1080/2162402X.2020.1779990 10.1242/jcs.259188 10.1016/j.ejca.2009.10.014 10.1158/1535-7163.MCT-10-0010 10.1016/j.canlet.2011.12.025 10.1111/febs.13604 |
ContentType | Journal Article |
Copyright | 2023 Elsevier Inc. Copyright © 2023 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier Inc. – notice: Copyright © 2023 Elsevier Inc. All rights reserved. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.cellsig.2023.110738 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1873-3913 |
EndPage | 110738 |
ExternalDocumentID | 10_1016_j_cellsig_2023_110738 37269960 S0898656823001523 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K WUQ ZGI ~G- AAXKI AFJKZ AKRWK NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c365t-ee130303a451ff7171c5f36c1a4619c232d6b3210d8b7b08ec09dd1b5e006a303 |
IEDL.DBID | AIKHN |
ISSN | 0898-6568 |
IngestDate | Sat Oct 05 06:08:39 EDT 2024 Thu Sep 26 17:52:44 EDT 2024 Wed Oct 16 00:39:15 EDT 2024 Fri Feb 23 02:34:21 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | YAP1 H2AX SLC46A1 CXCL8 DNA damage SHMT1 TYMS SASP RFC IDH1 mutation DDR GBM FBP SLC19A1 Immune response PCFT MGMT IDH1 2-HG LGG TCGA DHFR IL6 TEAD Glioma IL8 ATM FOLR1 GAPDH |
Language | English |
License | Copyright © 2023 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c365t-ee130303a451ff7171c5f36c1a4619c232d6b3210d8b7b08ec09dd1b5e006a303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 37269960 |
PQID | 2822375577 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2822375577 crossref_primary_10_1016_j_cellsig_2023_110738 pubmed_primary_37269960 elsevier_sciencedirect_doi_10_1016_j_cellsig_2023_110738 |
PublicationCentury | 2000 |
PublicationDate | September 2023 2023-Sep 2023-09-00 20230901 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: September 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Cellular signalling |
PublicationTitleAlternate | Cell Signal |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Andrade, Mehta, Griffith, Panneerselvam, Srivastava, Kim, Janknecht, Herman, Ramesh, Munshi (bb0120) 2017; 8 Ahmad, Patrick, Sheikh, Sharma, Pathak, Malgulwar, Kumar, Joshi, Sarkar, Sen (bb0180) 2017; 143 Ducker, Rabinowitz (bb0225) 2017; 25 Necela, Crozier, Andorfer, Lewis-Tuffin, Kachergus, Geiger, Kalari, Serie, Sun, Moreno-Aspitia, O’Shannessy, Maltzman, McCullough, Pockaj, Cunliffe, Ballman, Thompson, Perez (bb0085) 2015; 10 Gieryng, Pszczolkowska, Walentynowicz, Rajan, Kaminska (bb0305) 2017; 97 Pombo Antunes, Scheyltjens, Duerinck, Neyns, Movahedi, Van Ginderachter (bb0325) 2020; 9 Xu, Yang, Liu, Yang, Wang, Kim, Ito, Yang, Wang, Xiao, Liu, Jiang, Liu, Zhang, Wang, Frye, Zhang, Xu, Lei, Guan, Zhao, Xiong (bb0035) 2011; 19 Wang, Luo, Li, Tian, Chen, Huang, Liu, Deng, Lau, Wan, Ai, Mak, Tong, Kwan, Wang, Chiu, Zhu, Huang (bb0155) 2016; 540 SongTao, Lei, Si, YanQing, HuiXia, XueLin, LanXiao, Fei (bb0285) 2012; 103 Pefani, O’Neill (bb0125) 2016; 283 Orr, Bai, Odia, Jain, Anders, Eberhart (bb0105) 2011; 70 Wang, Kohli, Demaria (bb0130) 2020; 6 Holst, Christensen, Vitting-Seerup, Skjoth-Rasmussen, Hamerlik, Poulsen, Johansen (bb0300) 2021; 3 Varghese, Bukhari, Malhotra, De (bb0185) 2014; 9 Podhorecka, Skladanowski, Bozko (bb0230) 2010; 2010 Cancer Genome Atlas Research, Brat, Verhaak, Aldape, Yung, Salama, Cooper, Rheinbay, Miller, Vitucci, Morozova, Robertson, Noushmehr, Laird, Cherniack, Akbani, Huse, Ciriello, Poisson, Barnholtz-Sloan, Berger, Brennan, Colen, Colman, Flanders, Giannini, Grifford, Iavarone, Jain, Joseph, Kim, Kasaian, Mikkelsen, Murray, O’Neill, Pachter, Parsons, Sougnez, Sulman, Vandenberg, Van Meir, von Deimling, Zhang, Crain, Lau, Mallery, Morris, Paulauskis, Penny, Shelton, Sherman, Yena, Black, Bowen, Dicostanzo, Gastier-Foster, Leraas, Lichtenberg, Pierson, Ramirez, Taylor, Weaver, Wise, Zmuda, Davidsen, Demchok, Eley, Ferguson, Hutter, Mills Shaw, Ozenberger, Sheth, Sofia, Tarnuzzer, Wang, Yang, Zenklusen, Ayala, Baboud, Chudamani, Jensen, Liu, Pihl, Raman, Wan, Wu, Ally, Auman, Balasundaram, Balu, Baylin, Beroukhim, Bootwalla, Bowlby, Bristow, Brooks, Butterfield, Carlsen, Carter, Chin, Chu, Chuah, Cibulskis, Clarke, Coetzee, Dhalla, Fennell, Fisher, Gabriel, Getz, Gibbs, Guin, Hadjipanayis, Hayes, Hinoue, Hoadley, Holt, Hoyle, Jefferys, Jones, Jones, Kucherlapati, Lai, Lander, Lee, Lichtenstein, Ma, Maglinte, Mahadeshwar, Marra, Mayo, Meng, Meyerson, Mieczkowski, Moore, Mose, Mungall, Pantazi, Parfenov, Park, Parker, Perou, Protopopov, Ren, Roach, Sabedot, Schein, Schumacher, Seidman, Seth, Shen, Simons, Sipahimalani, Soloway, Song, Sun, Tabak, Tam, Tan, Tang, Thiessen, Triche, Van Den Berg, Veluvolu, Waring, Weisenberger, Wilkerson, Wong, Wu, Xi, Xu, Yang, Zack, Zhang, Aksoy, Arachchi, Benz, Bernard, Carlin, Cho, DiCara, Frazer, Fuller, Gao, Gehlenborg, Haussler, Heiman, Iype, Jacobsen, Ju, Katzman, Kim, Knijnenburg, Kreisberg, Lawrence, Lee, Leinonen, Lin, Ling, Liu, Liu, Liu, Lu, Mills, Ng, Noble, Paull, Rao, Reynolds, Saksena, Sanborn, Sander, Schultz, Senbabaoglu, Shen, Shmulevich, Sinha, Stuart, Sumer, Sun, Tasman, Taylor, Voet, Weinhold, Weinstein, Yang, Yoshihara, Zheng, Zhang, Zou, Abel, Sadeghi, Cohen, Eschbacher, Hattab, Raghunathan, Schniederjan, Aziz, Barnett, Barrett, Bigner, Boice, Brewer, Calatozzolo, Campos, Carlotti, Chan, Cuppini, Curley, Cuzzubbo, Devine, DiMeco, Duell, Elder, Fehrenbach, Finocchiaro, Friedman, Fulop, Gardner, Hermes, Herold-Mende, Jungk, Kendler, Lehman, Lipp, Liu, Mandt, McGraw, McLendon, McPherson, Neder, Nguyen, Noss, Nunziata, Ostrom, Palmer, Perin, Pollo, Potapov, Potapova, Rathmell, Rotin, Scarpace, Schilero, Senecal, Shimmel, Shurkhay, Sifri, Singh, Sloan, Smolenski, Staugaitis, Steele, Thorne, Tirapelli, Unterberg, Vallurupalli, Wang, Warnick, Williams, Wolinsky, Bell, Rosenberg, Stewart, Huang, Grimsby, Radenbaugh, Zhang (bb0025) 2015; 372 Jane, Pollack (bb0250) 2010; 46 Amankulor, Kim, Arora, Kargl, Szulzewsky, Hanke, Margineantu, Rao, Bolouri, Delrow, Hockenbery, Houghton, Holland (bb0320) 2017; 31 Ivashkevich, Redon, Nakamura, Martin, Martin (bb0260) 2012; 327 Wang, Lathia, Wu, Wang, Li, Heddleston, Eyler, Elderbroom, Gallagher, Schuschu, MacSwords, Cao, McLendon, Wang, Hjelmeland, Rich (bb0295) 2009; 27 Marinari, Allard, Gustave, Widmer, Philippin, Merkler, Tsantoulis, Dutoit, Dietrich (bb0310) 2020; 9 Bobola, Kolstoe, Blank, Silber (bb0255) 2010; 9 Sulkowski, Corso, Robinson, Scanlon, Purshouse, Bai, Liu, Sundaram, Hegan, Fons, Breuer, Song, Mishra-Gorur, De Feyter, de Graaf, Surovtseva, Kachman, Halene, Gunel, Glazer, Bindra (bb0165) 2017; 9 Matsuo, Kamatani, Hamba, Boroevich, Tsunoda (bb0315) 2022; 23 Hanahan, Weinberg (bb0010) 2011; 144 Sato, Kurose, Ogawa, Ogasawara, Traganos, Darzynkiewicz, Sawai (bb0270) 2009; 8 Wu, Zhan, Qu, Qi, Li, Yu (bb0090) 2014; 52 Metsalu, Vilo (bb0195) 2015; 43 Patrick, Gowda, Lathoria, Suri, Sen (bb0160) 2021; 134 Zhan, Ma, Wei, Lal, Fu, Eberhart, Laterra, Ying, Li, Meeker, Lopez-Bertoni, Xia (bb0170) 2021; 19 Lee, Ou, Huang, Hou, Creighton, Lin, Hu, Lin (bb0115) 2021; 40 Cerami, Gao, Dogrusoz, Gross, Sumer, Aksoy, Jacobsen, Byrne, Heuer, Larsson, Antipin, Reva, Goldberg, Sander, Schultz (bb0190) 2012; 2 Guichet, Masliantsev, Tachon, Petropoulos, Godet, Larrieu, Milin, Wager, Karayan-Tapon (bb0110) 2018; 246 Kuilman, Michaloglou, Vredeveld, Douma, van Doorn, Desmet, Aarden, Mooi, Peeper (bb0145) 2008; 133 Zhang, Wang, Zhou, Wang, Wang, Wang, Jiang, Zhao, Yu, Zhou (bb0240) 2021; 40 McCord, Pawar, Koneru, Tatiparti, Sau, Iyer (bb0080) 2021; 6 Roos, Thomas, Kaina (bb0005) 2016; 16 Dang, White, Gross, Bennett, Bittinger, Driggers, Fantin, Jang, Jin, Keenan, Marks, Prins, Ward, Yen, Liau, Rabinowitz, Cantley, Thompson, Vander Heiden, Su (bb0030) 2010; 465 Fack, Tardito, Hochart, Oudin, Zheng, Fritah, Golebiewska, Nazarov, Bernard, Hau, Keunen, Leenders, Lund-Johansen, Stauber, Gottlieb, Bjerkvig, Niclou (bb0040) 2017; 9 Rodier, Coppe, Patil, Hoeijmakers, Munoz, Raza, Freund, Campeau, Davalos, Campisi (bb0135) 2009; 11 Molenaar, Verbaan, Lamba, Zanon, Jeuken, Boots-Sprenger, Wesseling, Hulsebos, Troost, van Tilborg, Leenstra, Vandertop, Bardelli, van Noorden, Bleeker (bb0055) 2014; 16 Budczies, Klauschen, Sinn, Gyorffy, Schmitt, Darb-Esfahani, Denkert (bb0210) 2012; 7 Huang, Wu, Barrera, Matthews, Pan (bb0095) 2005; 122 Newman, Steen, Liu, Gentles, Chaudhuri, Scherer, Khodadoust, Esfahani, Luca, Steiner, Diehn, Alizadeh (bb0220) 2019; 37 Fishel, He, Smith, Kelley (bb0275) 2007; 13 Zhao, Zhang, Wang, Li, Zeng, Zhang, Wu, Chai, Wang, Zhang, Zhang, Bao, Jiang (bb0200) 2021; 19 Tran, Lai, Li, Pope, Teixeira, Harris, Woodworth, Nghiemphu, Cloughesy, Ellingson (bb0050) 2014; 16 Bowman, Wang, Carro, Verhaak, Squatrito (bb0205) 2017; 19 Yoshihara, Shahmoradgoli, Martinez, Vegesna, Kim, Torres-Garcia, Trevino, Shen, Laird, Levine, Carter, Getz, Stemke-Hale, Mills, Verhaak (bb0215) 2013; 4 Nawaz, Kipreos (bb0070) 2022; 33 Roos, Frohnapfel, Quiros, Ringel, Kaina (bb0280) 2018; 424 Ciamporcero, Shen, Ramakrishnan, Yu Ku, Chintala, Shen, Adelaiye, Miles, Ullio, Pizzimenti, Daga, Azabdaftari, Attwood, Johnson, Zhang, Barrera, Pili (bb0235) 2016; 35 Zhao, Ye, Yu, Li, Li, Li, Yu, Lin, Wang, Chinnaiyan, Lai, Guan (bb0100) 2008; 22 Yan, Parsons, Jin, McLendon, Rasheed, Yuan, Kos, Batinic-Haberle, Jones, Riggins, Friedman, Friedman, Reardon, Herndon, Kinzler, Velculescu, Vogelstein, Bigner (bb0020) 2009; 360 Inoue, Li, Tseng, Beerman, Elia, Bendall, Lemonnier, Kron, Cescon, Hao, Lind, Takayama, Planello, Shen, Shih, Larsen, Li, Snow, Wakeham, Haight, Gorrini, Bassi, Thu, Murakami, Elford, Ueda, Straley, Yen, Melino, Cimmino, Aifantis, Levine, De Carvalho, Lupien, Rossi, Nolan, Cairns, Mak (bb0060) 2016; 30 Zheng, Cantley (bb0065) 2019; 216 Liu, Lian, Yao (bb0075) 2020; 25 Al-Moujahed, Brodowska, Stryjewski, Efstathiou, Vasilikos, Cichy, Miller, Gragoudas, Vavvas (bb0245) 2017; 7 Filippi-Chiela, Thome, Bueno e Silva, Pelegrini, Ledur, Garicochea, Zamin, Lenz (bb0265) 2013; 13 Ronchetti, Melucci, De Nicola, Goeman, Casini, Sperati, Pallocca, Terrenato, Pizzuti, Vici, Sergi, Di Lauro, Amoreo, Gallo, Diodoro, Pescarmona, Vitale, Barba, Buglioni, Mottolese, Fanciulli, De Maria, Maugeri-Sacca (bb0015) 2017; 140 Gowda, Patrick, Singh, Sheikh, Sen (bb0175) 2018; 38 Saleh, Tyutynuk-Massey, Cudjoe, Idowu, Landry, Gewirtz (bb0290) 2018; 8 Sanson, Marie, Paris, Idbaih, Laffaire, Ducray, El Hallani, Boisselier, Mokhtari, Hoang-Xuan, Delattre (bb0045) 2009; 27 Cinat, Coppes, Barazzuol (bb0140) 2021; 9 Wang, Song, Zhou, Kong (bb0150) 2019; 25 Ronchetti (10.1016/j.cellsig.2023.110738_bb0015) 2017; 140 Hanahan (10.1016/j.cellsig.2023.110738_bb0010) 2011; 144 Yoshihara (10.1016/j.cellsig.2023.110738_bb0215) 2013; 4 Wang (10.1016/j.cellsig.2023.110738_bb0150) 2019; 25 Pombo Antunes (10.1016/j.cellsig.2023.110738_bb0325) 2020; 9 Zhang (10.1016/j.cellsig.2023.110738_bb0240) 2021; 40 Tran (10.1016/j.cellsig.2023.110738_bb0050) 2014; 16 Jane (10.1016/j.cellsig.2023.110738_bb0250) 2010; 46 Roos (10.1016/j.cellsig.2023.110738_bb0280) 2018; 424 Matsuo (10.1016/j.cellsig.2023.110738_bb0315) 2022; 23 Cancer Genome Atlas Research (10.1016/j.cellsig.2023.110738_bb0025) 2015; 372 Zhan (10.1016/j.cellsig.2023.110738_bb0170) 2021; 19 Zheng (10.1016/j.cellsig.2023.110738_bb0065) 2019; 216 Yan (10.1016/j.cellsig.2023.110738_bb0020) 2009; 360 Kuilman (10.1016/j.cellsig.2023.110738_bb0145) 2008; 133 Huang (10.1016/j.cellsig.2023.110738_bb0095) 2005; 122 Patrick (10.1016/j.cellsig.2023.110738_bb0160) 2021; 134 Cerami (10.1016/j.cellsig.2023.110738_bb0190) 2012; 2 Andrade (10.1016/j.cellsig.2023.110738_bb0120) 2017; 8 Ahmad (10.1016/j.cellsig.2023.110738_bb0180) 2017; 143 Podhorecka (10.1016/j.cellsig.2023.110738_bb0230) 2010; 2010 Bowman (10.1016/j.cellsig.2023.110738_bb0205) 2017; 19 Lee (10.1016/j.cellsig.2023.110738_bb0115) 2021; 40 Amankulor (10.1016/j.cellsig.2023.110738_bb0320) 2017; 31 Roos (10.1016/j.cellsig.2023.110738_bb0005) 2016; 16 Marinari (10.1016/j.cellsig.2023.110738_bb0310) 2020; 9 Sanson (10.1016/j.cellsig.2023.110738_bb0045) 2009; 27 Orr (10.1016/j.cellsig.2023.110738_bb0105) 2011; 70 SongTao (10.1016/j.cellsig.2023.110738_bb0285) 2012; 103 Bobola (10.1016/j.cellsig.2023.110738_bb0255) 2010; 9 Rodier (10.1016/j.cellsig.2023.110738_bb0135) 2009; 11 Newman (10.1016/j.cellsig.2023.110738_bb0220) 2019; 37 Necela (10.1016/j.cellsig.2023.110738_bb0085) 2015; 10 Varghese (10.1016/j.cellsig.2023.110738_bb0185) 2014; 9 Wu (10.1016/j.cellsig.2023.110738_bb0090) 2014; 52 Wang (10.1016/j.cellsig.2023.110738_bb0130) 2020; 6 Molenaar (10.1016/j.cellsig.2023.110738_bb0055) 2014; 16 Pefani (10.1016/j.cellsig.2023.110738_bb0125) 2016; 283 Zhao (10.1016/j.cellsig.2023.110738_bb0200) 2021; 19 Inoue (10.1016/j.cellsig.2023.110738_bb0060) 2016; 30 Dang (10.1016/j.cellsig.2023.110738_bb0030) 2010; 465 Wang (10.1016/j.cellsig.2023.110738_bb0155) 2016; 540 Al-Moujahed (10.1016/j.cellsig.2023.110738_bb0245) 2017; 7 McCord (10.1016/j.cellsig.2023.110738_bb0080) 2021; 6 Guichet (10.1016/j.cellsig.2023.110738_bb0110) 2018; 246 Filippi-Chiela (10.1016/j.cellsig.2023.110738_bb0265) 2013; 13 Cinat (10.1016/j.cellsig.2023.110738_bb0140) 2021; 9 Wang (10.1016/j.cellsig.2023.110738_bb0295) 2009; 27 Ivashkevich (10.1016/j.cellsig.2023.110738_bb0260) 2012; 327 Xu (10.1016/j.cellsig.2023.110738_bb0035) 2011; 19 Ducker (10.1016/j.cellsig.2023.110738_bb0225) 2017; 25 Fishel (10.1016/j.cellsig.2023.110738_bb0275) 2007; 13 Fack (10.1016/j.cellsig.2023.110738_bb0040) 2017; 9 Sulkowski (10.1016/j.cellsig.2023.110738_bb0165) 2017; 9 Ciamporcero (10.1016/j.cellsig.2023.110738_bb0235) 2016; 35 Sato (10.1016/j.cellsig.2023.110738_bb0270) 2009; 8 Holst (10.1016/j.cellsig.2023.110738_bb0300) 2021; 3 Budczies (10.1016/j.cellsig.2023.110738_bb0210) 2012; 7 Saleh (10.1016/j.cellsig.2023.110738_bb0290) 2018; 8 Nawaz (10.1016/j.cellsig.2023.110738_bb0070) 2022; 33 Gowda (10.1016/j.cellsig.2023.110738_bb0175) 2018; 38 Metsalu (10.1016/j.cellsig.2023.110738_bb0195) 2015; 43 Liu (10.1016/j.cellsig.2023.110738_bb0075) 2020; 25 Gieryng (10.1016/j.cellsig.2023.110738_bb0305) 2017; 97 Zhao (10.1016/j.cellsig.2023.110738_bb0100) 2008; 22 |
References_xml | – volume: 13 start-page: 260 year: 2007 end-page: 267 ident: bb0275 article-title: Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide publication-title: Clin. Cancer Res. contributor: fullname: Kelley – volume: 9 year: 2021 ident: bb0140 article-title: DNA damage-induced inflammatory microenvironment and adult stem cell response publication-title: Front. Cell Dev. Biol. contributor: fullname: Barazzuol – volume: 16 start-page: 20 year: 2016 end-page: 33 ident: bb0005 article-title: DNA damage and the balance between survival and death in cancer biology publication-title: Nat. Rev. Cancer contributor: fullname: Kaina – volume: 46 start-page: 412 year: 2010 end-page: 419 ident: bb0250 article-title: Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells publication-title: Eur. J. Cancer contributor: fullname: Pollack – volume: 27 start-page: 4150 year: 2009 end-page: 4154 ident: bb0045 article-title: Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas publication-title: J. Clin. Oncol. contributor: fullname: Delattre – volume: 465 start-page: 966 year: 2010 ident: bb0030 article-title: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate publication-title: Nature contributor: fullname: Su – volume: 19 start-page: 1878 year: 2021 end-page: 1888 ident: bb0170 article-title: Monoallelic IDH1 R132H mutation mediates glioma cell response to anticancer therapies via induction of senescence publication-title: Mol. Cancer Res. contributor: fullname: Xia – volume: 8 start-page: 452 year: 2009 end-page: 457 ident: bb0270 article-title: Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide publication-title: Cancer Biol. Ther. contributor: fullname: Sawai – volume: 11 start-page: 973 year: 2009 end-page: 979 ident: bb0135 article-title: Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion publication-title: Nat. Cell Biol. contributor: fullname: Campisi – volume: 143 start-page: 671 year: 2017 end-page: 683 ident: bb0180 article-title: Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma publication-title: J. Neurochem. contributor: fullname: Sen – volume: 25 start-page: 27 year: 2017 end-page: 42 ident: bb0225 article-title: One-carbon metabolism in health and disease publication-title: Cell Metab. contributor: fullname: Rabinowitz – volume: 540 start-page: 579 year: 2016 end-page: 582 ident: bb0155 article-title: Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow publication-title: Nature contributor: fullname: Huang – volume: 43 start-page: W566 year: 2015 end-page: W570 ident: bb0195 article-title: ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap publication-title: Nucleic Acids Res. contributor: fullname: Vilo – volume: 40 start-page: 4580 year: 2021 end-page: 4591 ident: bb0240 article-title: Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair publication-title: Oncogene contributor: fullname: Zhou – volume: 25 start-page: 367 year: 2020 end-page: 374 ident: bb0075 article-title: A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis publication-title: Biomarkers contributor: fullname: Yao – volume: 9 year: 2017 ident: bb0165 article-title: 2-hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity publication-title: Sci. Transl. Med. contributor: fullname: Bindra – volume: 424 start-page: 119 year: 2018 end-page: 126 ident: bb0280 article-title: XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair publication-title: Cancer Lett. contributor: fullname: Kaina – volume: 9 start-page: 1208 year: 2010 end-page: 1218 ident: bb0255 article-title: Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression publication-title: Mol. Cancer Ther. contributor: fullname: Silber – volume: 9 start-page: 1779990 year: 2020 ident: bb0310 article-title: Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma publication-title: Oncoimmunology contributor: fullname: Dietrich – volume: 25 start-page: 32 year: 2019 ident: bb0150 article-title: YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11 publication-title: Mol. Med. contributor: fullname: Kong – volume: 16 start-page: 1263 year: 2014 end-page: 1273 ident: bb0055 article-title: The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone publication-title: Neuro-Oncology contributor: fullname: Bleeker – volume: 2010 year: 2010 ident: bb0230 article-title: H2AX phosphorylation: its role in DNA damage response and cancer therapy publication-title: J. Nucleic Acids contributor: fullname: Bozko – volume: 3 year: 2021 ident: bb0300 article-title: Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma publication-title: Neuro-Oncol. Adv. contributor: fullname: Johansen – volume: 22 start-page: 1962 year: 2008 end-page: 1971 ident: bb0100 article-title: TEAD mediates YAP-dependent gene induction and growth control publication-title: Genes Dev. contributor: fullname: Guan – volume: 37 start-page: 773 year: 2019 end-page: 782 ident: bb0220 article-title: Determining cell type abundance and expression from bulk tissues with digital cytometry publication-title: Nat. Biotechnol. contributor: fullname: Alizadeh – volume: 122 start-page: 421 year: 2005 end-page: 434 ident: bb0095 article-title: The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the drosophila homolog of YAP publication-title: Cell contributor: fullname: Pan – volume: 8 start-page: 98495 year: 2017 end-page: 98508 ident: bb0120 article-title: YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways publication-title: Oncotarget contributor: fullname: Munshi – volume: 2 start-page: 401 year: 2012 end-page: 404 ident: bb0190 article-title: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data publication-title: Cancer Discov. contributor: fullname: Schultz – volume: 10 year: 2015 ident: bb0085 article-title: Folate receptor-alpha (FOLR1) expression and function in triple negative tumors publication-title: PLoS One contributor: fullname: Perez – volume: 9 year: 2014 ident: bb0185 article-title: IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples publication-title: PLoS One contributor: fullname: De – volume: 35 start-page: 1541 year: 2016 end-page: 1553 ident: bb0235 article-title: YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage publication-title: Oncogene contributor: fullname: Pili – volume: 6 start-page: 838 year: 2020 end-page: 857 ident: bb0130 article-title: Senescent cells in cancer therapy: friends or foes? publication-title: Trends Cancer contributor: fullname: Demaria – volume: 327 start-page: 123 year: 2012 end-page: 133 ident: bb0260 article-title: Use of the gamma-H2AX assay to monitor DNA damage and repair in translational cancer research publication-title: Cancer Lett. contributor: fullname: Martin – volume: 7 year: 2012 ident: bb0210 article-title: Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization publication-title: PLoS One contributor: fullname: Denkert – volume: 103 start-page: 269 year: 2012 end-page: 273 ident: bb0285 article-title: IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma publication-title: Cancer Sci. contributor: fullname: Fei – volume: 19 start-page: 17 year: 2011 end-page: 30 ident: bb0035 article-title: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases publication-title: Cancer Cell contributor: fullname: Xiong – volume: 360 start-page: 765 year: 2009 end-page: 773 ident: bb0020 article-title: IDH1 and IDH2 mutations in gliomas publication-title: N. Engl. J. Med. contributor: fullname: Bigner – volume: 33 start-page: 159 year: 2022 end-page: 174 ident: bb0070 article-title: Emerging roles for folate receptor FOLR1 in signaling and cancer publication-title: Trends Endocrinol. Metab. contributor: fullname: Kipreos – volume: 9 year: 2020 ident: bb0325 article-title: Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies publication-title: Elife contributor: fullname: Van Ginderachter – volume: 6 start-page: 4111 year: 2021 end-page: 4118 ident: bb0080 article-title: Folate receptors’ expression in gliomas may possess potential nanoparticle-based drug delivery opportunities publication-title: ACS Omega contributor: fullname: Iyer – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: bb0010 article-title: Hallmarks of cancer: the next generation publication-title: Cell contributor: fullname: Weinberg – volume: 30 start-page: 337 year: 2016 end-page: 348 ident: bb0060 article-title: Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2 publication-title: Cancer Cell contributor: fullname: Mak – volume: 31 start-page: 774 year: 2017 end-page: 786 ident: bb0320 article-title: Mutant IDH1 regulates the tumor-associated immune system in gliomas publication-title: Genes Dev. contributor: fullname: Holland – volume: 52 start-page: 202 year: 2014 end-page: 207 ident: bb0090 article-title: Changes of folate receptor -alpha protein expression in human gliomas and its clinical relevance publication-title: Zhonghua Wai Ke Za Zhi contributor: fullname: Yu – volume: 19 start-page: 1 year: 2021 end-page: 12 ident: bb0200 article-title: Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients publication-title: Genom. Proteom. Bioinform. contributor: fullname: Jiang – volume: 133 start-page: 1019 year: 2008 end-page: 1031 ident: bb0145 article-title: Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network publication-title: Cell contributor: fullname: Peeper – volume: 19 start-page: 139 year: 2017 end-page: 141 ident: bb0205 article-title: GlioVis data portal for visualization and analysis of brain tumor expression datasets publication-title: Neuro-Oncology contributor: fullname: Squatrito – volume: 134 year: 2021 ident: bb0160 article-title: YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas publication-title: J. Cell Sci. contributor: fullname: Sen – volume: 372 start-page: 2481 year: 2015 end-page: 2498 ident: bb0025 article-title: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas publication-title: N. Engl. J. Med. contributor: fullname: Zhang – volume: 13 start-page: 147 year: 2013 ident: bb0265 article-title: Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells publication-title: BMC Cancer contributor: fullname: Lenz – volume: 27 start-page: 2393 year: 2009 end-page: 2404 ident: bb0295 article-title: Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth publication-title: Stem Cells contributor: fullname: Rich – volume: 246 start-page: 205 year: 2018 end-page: 216 ident: bb0110 article-title: Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence publication-title: J. Pathol. contributor: fullname: Karayan-Tapon – volume: 97 start-page: 498 year: 2017 end-page: 518 ident: bb0305 article-title: Immune microenvironment of gliomas publication-title: Lab. Investig. contributor: fullname: Kaminska – volume: 140 start-page: 2587 year: 2017 end-page: 2595 ident: bb0015 article-title: DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy publication-title: Int. J. Cancer contributor: fullname: Maugeri-Sacca – volume: 8 start-page: 164 year: 2018 ident: bb0290 article-title: Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy publication-title: Front. Oncol. contributor: fullname: Gewirtz – volume: 216 start-page: 253 year: 2019 end-page: 266 ident: bb0065 article-title: Toward a better understanding of folate metabolism in health and disease publication-title: J. Exp. Med. contributor: fullname: Cantley – volume: 7 start-page: 7602 year: 2017 ident: bb0245 article-title: Verteporfin inhibits growth of human glioma in vitro without light activation publication-title: Sci. Rep. contributor: fullname: Vavvas – volume: 16 start-page: 414 year: 2014 end-page: 420 ident: bb0050 article-title: Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry publication-title: Neuro-Oncology contributor: fullname: Ellingson – volume: 38 year: 2018 ident: bb0175 article-title: Mutant Isocitrate dehydrogenase 1 disrupts PKM2-beta-catenin-BRG1 transcriptional network-driven CD47 expression publication-title: Mol. Cell. Biol. contributor: fullname: Sen – volume: 23 start-page: 351 year: 2022 ident: bb0315 article-title: Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data publication-title: BMC Genomics contributor: fullname: Tsunoda – volume: 283 start-page: 1392 year: 2016 end-page: 1403 ident: bb0125 article-title: Hippo pathway and protection of genome stability in response to DNA damage publication-title: FEBS J. contributor: fullname: O’Neill – volume: 4 start-page: 2612 year: 2013 ident: bb0215 article-title: Inferring tumour purity and stromal and immune cell admixture from expression data publication-title: Nat. Commun. contributor: fullname: Verhaak – volume: 70 start-page: 568 year: 2011 end-page: 577 ident: bb0105 article-title: Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth publication-title: J. Neuropathol. Exp. Neurol. contributor: fullname: Eberhart – volume: 40 start-page: 2407 year: 2021 end-page: 2421 ident: bb0115 article-title: YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer publication-title: Oncogene contributor: fullname: Lin – volume: 9 start-page: 1681 year: 2017 end-page: 1695 ident: bb0040 article-title: Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways publication-title: EMBO Mol. Med. contributor: fullname: Niclou – volume: 140 start-page: 2587 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0015 article-title: DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy publication-title: Int. J. Cancer doi: 10.1002/ijc.30668 contributor: fullname: Ronchetti – volume: 465 start-page: 966 year: 2010 ident: 10.1016/j.cellsig.2023.110738_bb0030 article-title: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate publication-title: Nature doi: 10.1038/nature09132 contributor: fullname: Dang – volume: 424 start-page: 119 year: 2018 ident: 10.1016/j.cellsig.2023.110738_bb0280 article-title: XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair publication-title: Cancer Lett. doi: 10.1016/j.canlet.2018.03.025 contributor: fullname: Roos – volume: 19 start-page: 1 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0200 article-title: Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients publication-title: Genom. Proteom. Bioinform. doi: 10.1016/j.gpb.2020.10.005 contributor: fullname: Zhao – volume: 4 start-page: 2612 year: 2013 ident: 10.1016/j.cellsig.2023.110738_bb0215 article-title: Inferring tumour purity and stromal and immune cell admixture from expression data publication-title: Nat. Commun. doi: 10.1038/ncomms3612 contributor: fullname: Yoshihara – volume: 22 start-page: 1962 year: 2008 ident: 10.1016/j.cellsig.2023.110738_bb0100 article-title: TEAD mediates YAP-dependent gene induction and growth control publication-title: Genes Dev. doi: 10.1101/gad.1664408 contributor: fullname: Zhao – volume: 97 start-page: 498 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0305 article-title: Immune microenvironment of gliomas publication-title: Lab. Investig. doi: 10.1038/labinvest.2017.19 contributor: fullname: Gieryng – volume: 3 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0300 article-title: Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma publication-title: Neuro-Oncol. Adv. contributor: fullname: Holst – volume: 143 start-page: 671 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0180 article-title: Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma publication-title: J. Neurochem. doi: 10.1111/jnc.14152 contributor: fullname: Ahmad – volume: 33 start-page: 159 year: 2022 ident: 10.1016/j.cellsig.2023.110738_bb0070 article-title: Emerging roles for folate receptor FOLR1 in signaling and cancer publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2021.12.003 contributor: fullname: Nawaz – volume: 9 year: 2020 ident: 10.1016/j.cellsig.2023.110738_bb0325 article-title: Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies publication-title: Elife doi: 10.7554/eLife.52176 contributor: fullname: Pombo Antunes – volume: 2 start-page: 401 year: 2012 ident: 10.1016/j.cellsig.2023.110738_bb0190 article-title: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-12-0095 contributor: fullname: Cerami – volume: 16 start-page: 414 year: 2014 ident: 10.1016/j.cellsig.2023.110738_bb0050 article-title: Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry publication-title: Neuro-Oncology doi: 10.1093/neuonc/not198 contributor: fullname: Tran – volume: 43 start-page: W566 year: 2015 ident: 10.1016/j.cellsig.2023.110738_bb0195 article-title: ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv468 contributor: fullname: Metsalu – volume: 8 start-page: 452 year: 2009 ident: 10.1016/j.cellsig.2023.110738_bb0270 article-title: Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.8.5.7740 contributor: fullname: Sato – volume: 372 start-page: 2481 year: 2015 ident: 10.1016/j.cellsig.2023.110738_bb0025 article-title: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1402121 contributor: fullname: Cancer Genome Atlas Research – volume: 25 start-page: 367 year: 2020 ident: 10.1016/j.cellsig.2023.110738_bb0075 article-title: A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis publication-title: Biomarkers doi: 10.1080/1354750X.2020.1771420 contributor: fullname: Liu – volume: 246 start-page: 205 year: 2018 ident: 10.1016/j.cellsig.2023.110738_bb0110 article-title: Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence publication-title: J. Pathol. doi: 10.1002/path.5133 contributor: fullname: Guichet – volume: 13 start-page: 147 year: 2013 ident: 10.1016/j.cellsig.2023.110738_bb0265 article-title: Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells publication-title: BMC Cancer doi: 10.1186/1471-2407-13-147 contributor: fullname: Filippi-Chiela – volume: 103 start-page: 269 year: 2012 ident: 10.1016/j.cellsig.2023.110738_bb0285 article-title: IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2011.02134.x contributor: fullname: SongTao – volume: 40 start-page: 4580 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0240 article-title: Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair publication-title: Oncogene doi: 10.1038/s41388-021-01878-3 contributor: fullname: Zhang – volume: 38 year: 2018 ident: 10.1016/j.cellsig.2023.110738_bb0175 article-title: Mutant Isocitrate dehydrogenase 1 disrupts PKM2-beta-catenin-BRG1 transcriptional network-driven CD47 expression publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.00001-18 contributor: fullname: Gowda – volume: 35 start-page: 1541 year: 2016 ident: 10.1016/j.cellsig.2023.110738_bb0235 article-title: YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage publication-title: Oncogene doi: 10.1038/onc.2015.219 contributor: fullname: Ciamporcero – volume: 6 start-page: 4111 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0080 article-title: Folate receptors’ expression in gliomas may possess potential nanoparticle-based drug delivery opportunities publication-title: ACS Omega doi: 10.1021/acsomega.0c05500 contributor: fullname: McCord – volume: 23 start-page: 351 year: 2022 ident: 10.1016/j.cellsig.2023.110738_bb0315 article-title: Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data publication-title: BMC Genomics doi: 10.1186/s12864-022-08586-6 contributor: fullname: Matsuo – volume: 27 start-page: 2393 year: 2009 ident: 10.1016/j.cellsig.2023.110738_bb0295 article-title: Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth publication-title: Stem Cells doi: 10.1002/stem.188 contributor: fullname: Wang – volume: 7 start-page: 7602 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0245 article-title: Verteporfin inhibits growth of human glioma in vitro without light activation publication-title: Sci. Rep. doi: 10.1038/s41598-017-07632-8 contributor: fullname: Al-Moujahed – volume: 37 start-page: 773 year: 2019 ident: 10.1016/j.cellsig.2023.110738_bb0220 article-title: Determining cell type abundance and expression from bulk tissues with digital cytometry publication-title: Nat. Biotechnol. doi: 10.1038/s41587-019-0114-2 contributor: fullname: Newman – volume: 27 start-page: 4150 year: 2009 ident: 10.1016/j.cellsig.2023.110738_bb0045 article-title: Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2009.21.9832 contributor: fullname: Sanson – volume: 70 start-page: 568 year: 2011 ident: 10.1016/j.cellsig.2023.110738_bb0105 article-title: Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e31821ff8d8 contributor: fullname: Orr – volume: 540 start-page: 579 year: 2016 ident: 10.1016/j.cellsig.2023.110738_bb0155 article-title: Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow publication-title: Nature doi: 10.1038/nature20602 contributor: fullname: Wang – volume: 19 start-page: 139 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0205 article-title: GlioVis data portal for visualization and analysis of brain tumor expression datasets publication-title: Neuro-Oncology doi: 10.1093/neuonc/now247 contributor: fullname: Bowman – volume: 31 start-page: 774 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0320 article-title: Mutant IDH1 regulates the tumor-associated immune system in gliomas publication-title: Genes Dev. doi: 10.1101/gad.294991.116 contributor: fullname: Amankulor – volume: 19 start-page: 17 year: 2011 ident: 10.1016/j.cellsig.2023.110738_bb0035 article-title: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.12.014 contributor: fullname: Xu – volume: 9 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0140 article-title: DNA damage-induced inflammatory microenvironment and adult stem cell response publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2021.729136 contributor: fullname: Cinat – volume: 144 start-page: 646 year: 2011 ident: 10.1016/j.cellsig.2023.110738_bb0010 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 contributor: fullname: Hanahan – volume: 9 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0165 article-title: 2-hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aal2463 contributor: fullname: Sulkowski – volume: 2010 year: 2010 ident: 10.1016/j.cellsig.2023.110738_bb0230 article-title: H2AX phosphorylation: its role in DNA damage response and cancer therapy publication-title: J. Nucleic Acids doi: 10.4061/2010/920161 contributor: fullname: Podhorecka – volume: 11 start-page: 973 year: 2009 ident: 10.1016/j.cellsig.2023.110738_bb0135 article-title: Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion publication-title: Nat. Cell Biol. doi: 10.1038/ncb1909 contributor: fullname: Rodier – volume: 52 start-page: 202 year: 2014 ident: 10.1016/j.cellsig.2023.110738_bb0090 article-title: Changes of folate receptor -alpha protein expression in human gliomas and its clinical relevance publication-title: Zhonghua Wai Ke Za Zhi contributor: fullname: Wu – volume: 133 start-page: 1019 year: 2008 ident: 10.1016/j.cellsig.2023.110738_bb0145 article-title: Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network publication-title: Cell doi: 10.1016/j.cell.2008.03.039 contributor: fullname: Kuilman – volume: 8 start-page: 164 year: 2018 ident: 10.1016/j.cellsig.2023.110738_bb0290 article-title: Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy publication-title: Front. Oncol. doi: 10.3389/fonc.2018.00164 contributor: fullname: Saleh – volume: 25 start-page: 32 year: 2019 ident: 10.1016/j.cellsig.2023.110738_bb0150 article-title: YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11 publication-title: Mol. Med. doi: 10.1186/s10020-019-0103-4 contributor: fullname: Wang – volume: 122 start-page: 421 year: 2005 ident: 10.1016/j.cellsig.2023.110738_bb0095 article-title: The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the drosophila homolog of YAP publication-title: Cell doi: 10.1016/j.cell.2005.06.007 contributor: fullname: Huang – volume: 6 start-page: 838 year: 2020 ident: 10.1016/j.cellsig.2023.110738_bb0130 article-title: Senescent cells in cancer therapy: friends or foes? publication-title: Trends Cancer doi: 10.1016/j.trecan.2020.05.004 contributor: fullname: Wang – volume: 9 year: 2014 ident: 10.1016/j.cellsig.2023.110738_bb0185 article-title: IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples publication-title: PLoS One doi: 10.1371/journal.pone.0096801 contributor: fullname: Varghese – volume: 216 start-page: 253 year: 2019 ident: 10.1016/j.cellsig.2023.110738_bb0065 article-title: Toward a better understanding of folate metabolism in health and disease publication-title: J. Exp. Med. doi: 10.1084/jem.20181965 contributor: fullname: Zheng – volume: 40 start-page: 2407 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0115 article-title: YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer publication-title: Oncogene doi: 10.1038/s41388-021-01718-4 contributor: fullname: Lee – volume: 16 start-page: 20 year: 2016 ident: 10.1016/j.cellsig.2023.110738_bb0005 article-title: DNA damage and the balance between survival and death in cancer biology publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2015.2 contributor: fullname: Roos – volume: 25 start-page: 27 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0225 article-title: One-carbon metabolism in health and disease publication-title: Cell Metab. doi: 10.1016/j.cmet.2016.08.009 contributor: fullname: Ducker – volume: 13 start-page: 260 year: 2007 ident: 10.1016/j.cellsig.2023.110738_bb0275 article-title: Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-1920 contributor: fullname: Fishel – volume: 360 start-page: 765 year: 2009 ident: 10.1016/j.cellsig.2023.110738_bb0020 article-title: IDH1 and IDH2 mutations in gliomas publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0808710 contributor: fullname: Yan – volume: 16 start-page: 1263 year: 2014 ident: 10.1016/j.cellsig.2023.110738_bb0055 article-title: The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone publication-title: Neuro-Oncology doi: 10.1093/neuonc/nou005 contributor: fullname: Molenaar – volume: 8 start-page: 98495 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0120 article-title: YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways publication-title: Oncotarget doi: 10.18632/oncotarget.21913 contributor: fullname: Andrade – volume: 9 start-page: 1681 year: 2017 ident: 10.1016/j.cellsig.2023.110738_bb0040 article-title: Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201707729 contributor: fullname: Fack – volume: 30 start-page: 337 year: 2016 ident: 10.1016/j.cellsig.2023.110738_bb0060 article-title: Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.05.018 contributor: fullname: Inoue – volume: 19 start-page: 1878 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0170 article-title: Monoallelic IDH1 R132H mutation mediates glioma cell response to anticancer therapies via induction of senescence publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-21-0284 contributor: fullname: Zhan – volume: 7 year: 2012 ident: 10.1016/j.cellsig.2023.110738_bb0210 article-title: Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization publication-title: PLoS One doi: 10.1371/journal.pone.0051862 contributor: fullname: Budczies – volume: 9 start-page: 1779990 year: 2020 ident: 10.1016/j.cellsig.2023.110738_bb0310 article-title: Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma publication-title: Oncoimmunology doi: 10.1080/2162402X.2020.1779990 contributor: fullname: Marinari – volume: 134 year: 2021 ident: 10.1016/j.cellsig.2023.110738_bb0160 article-title: YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas publication-title: J. Cell Sci. doi: 10.1242/jcs.259188 contributor: fullname: Patrick – volume: 46 start-page: 412 year: 2010 ident: 10.1016/j.cellsig.2023.110738_bb0250 article-title: Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2009.10.014 contributor: fullname: Jane – volume: 10 year: 2015 ident: 10.1016/j.cellsig.2023.110738_bb0085 article-title: Folate receptor-alpha (FOLR1) expression and function in triple negative tumors publication-title: PLoS One contributor: fullname: Necela – volume: 9 start-page: 1208 year: 2010 ident: 10.1016/j.cellsig.2023.110738_bb0255 article-title: Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-10-0010 contributor: fullname: Bobola – volume: 327 start-page: 123 year: 2012 ident: 10.1016/j.cellsig.2023.110738_bb0260 article-title: Use of the gamma-H2AX assay to monitor DNA damage and repair in translational cancer research publication-title: Cancer Lett. doi: 10.1016/j.canlet.2011.12.025 contributor: fullname: Ivashkevich – volume: 283 start-page: 1392 year: 2016 ident: 10.1016/j.cellsig.2023.110738_bb0125 article-title: Hippo pathway and protection of genome stability in response to DNA damage publication-title: FEBS J. doi: 10.1111/febs.13604 contributor: fullname: Pefani |
SSID | ssj0015062 |
Score | 2.4646695 |
Snippet | Gliomas harbouring mutations in IDH1 (isocitrate dehydrogenase 1) are characterized by greater sensitivity to chemotherapeutics. These mutants also exhibit... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 110738 |
SubjectTerms | DNA damage FOLR1 Glioma IDH1 mutation Immune response YAP1 |
Title | Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics |
URI | https://dx.doi.org/10.1016/j.cellsig.2023.110738 https://www.ncbi.nlm.nih.gov/pubmed/37269960 https://search.proquest.com/docview/2822375577 |
Volume | 109 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50RfAivl1fRPDa3aZp2vS4iMv6WsUH6Ck0TSoV7S679eDF326mDx-gCB5bOjTMNDOTzvfNABxow9JEC-4kMVOOz1PhKD_1HE1j5btC6cBFvvP5MBjc-id3_G4GDhsuDMIqa99f-fTSW9d3urU2u-Ms6167IhI2G8FKkY1pHpuFORuOfL8Fc73j08Hwo5jA3XKuKD7voMAnkaf72MH_49PsoYNjxBETXzJVfg5Rv6WgZSjqL8FinUOSXrXMZZgx-QrMV1MlX1dheIXtWI0m971LSuJck_7F2RUlWU4enjLEA5HxBOszBVElmYdMKqCsIcWIWCM-f2VlTdfgtn90czhw6rEJTsICXjjGYFxyWexzmqb2uEYTnrIgobFvT0uJTaF0oJC6o4UKlStM4kZaU8WN3YGxFVyHVj7KzSYQK0a1YEYLbNSnolgEURB5WAT2rC2TNnQaTclx1R1DNrCxR1mrVqJqZaXaNohGn_KbmaX14H-J7jf6l3YL4BNxbkYvU4lIWBZyHoZt2KgM87EaFnoBNqDZ-v-Lt2EBrypg2Q60ismL2bWZSKH2YLbzRvfq7-0dCFnbQg |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BEYILYqesRuKaNonjxDlWiKpAKYhFgpMVx04VBGnVhgMXvh1PFhYJhMQ1sRXrTTwzybw3BjhSmiax4syKIyotjyXckl7iWsqJpGdzqXwb9c4XA793553ds_sZOK61MEirrHx_6dMLb11daVdotsdp2r6xechNNoKVIhPTXDoLc5gNIK-r9fbB88AOekUpwYy2cPinjKf92MK_49N02MJDxJERX-hUfg5QvyWgRSDqLsNSlUGSTrnIFZjR2SrMl2dKvq7B4BqbsWpFHjpXDokyRbqX_WuHpBkZPqXIBiLjCVZnciILKQ-ZlDRZTfIRMSZ8_qrJmq7DXffk9rhnVYcmWDH1WW5pjVHJppHHnCQxH2tOzBLqx07kmW-l2CRQypco3FFcBtLmOrZDpRzJtNl_kZm4AY1slOktIGaaozjVimObPhlG3A_90MUSsGssGTehVSMlxmVvDFGTxh5FBa1AaEUJbRN4jaf4ZmRh_PdfUw9r_IXZADgiyvToZSqQB0sDxoKgCZulYT5WQwPXx_Yz2_9_8AEs9G4v-qJ_OjjfgUW8U1LMdqGRT170nslJcrlfvHPv8yLcFw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+YAP1+and+FOLR1+in+gliomas+predict+better+response+to+chemotherapeutics&rft.jtitle=Cellular+signalling&rft.au=Patrick%2C+Shruti&rft.au=Lathoria%2C+Kirti&rft.au=Suri%2C+Vaishali&rft.au=Sen%2C+Ellora&rft.date=2023-09-01&rft.eissn=1873-3913&rft.volume=109&rft.spage=110738&rft.epage=110738&rft_id=info:doi/10.1016%2Fj.cellsig.2023.110738&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0898-6568&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0898-6568&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0898-6568&client=summon |